James Francis Demarest, PhD
Jim is the Director of Immunology Strategy overseeing the global immunology and diagnostics efforts for ViiV Healthcare (www.viivhealthcare.com).
He was most recently a Senior Chief Scientist in the GSK HIV Discovery Performance Unit with responsibilities for pre-clinical research surrounding novel host and immune-based targets related to HIV therapies. The previous 10 years at GSK/GlaxoWellcome he was involved in clinical-based research spanning Ph 1a through Ph 3b/4 of immune reconstitution, HIV vaccines, immune based therapies, and CCR5 antagonists.
Jim obtained his PhD from the George Washington University with research at the National Institutes of Health/NIAID. He did post-doctoral research at Duke University, where he is currently an Adjunct Assistant Professor.
Education and Training
- Ph.D., George Washington University, 1996